Caricamento...

ICAM-1 Targeting, Intracellular Trafficking, and Functional Activity of Polymer Nanocarriers Coated with a Fibrinogen-Derived Peptide for Lysosomal Enzyme Replacement

Enzyme replacement is a viable treatment for diseases caused by genetic deficiency of lysosomal enzymes. However, suboptimal access of enzymes to target sites limits this strategy. Polymer nanocarriers (NCs) coated with antibody against intercellular adhesion molecule 1 (ICAM-1), a protein overexpre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Drug Target
Autori principali: Garnacho, Carmen, Muro, Silvia
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828777/
https://ncbi.nlm.nih.gov/pubmed/28665212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1061186X.2017.1349771
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !